Ge Healthcare Technologies INC Form 4 insider transactions

GE HealthCare Technologies Inc. Director H. Lawrence Culp Jr. reported the acquisition of 6,675 shares of common stock on May 28, 2025, through restricted stock unit and deferred stock unit awards, increasing his direct and indirect beneficial ownership.

Jeannette Bankes, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the acquisition of stock options and restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., files an amended SEC Form 4 to correct the number of shares withheld for tax obligations related to vesting restricted stock units.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports acquisition and disposal of company stock and stock options.

Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the acquisition and disposal of company stock and stock options.

CEO Kevin O'Neill reports acquisition and disposal of GE HealthCare Technologies Inc. stock and stock options.

Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., reports acquisition of shares and stock options.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., reports acquisition of shares and stock options.

Chief Financial Officer James Saccaro of GE HealthCare Technologies Inc. reports the acquisition of restricted stock units and employee stock options.

CEO of Imaging, Roland Rott, reports acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports the acquisition of stock options and restricted stock units in the company.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports acquisition of shares and stock options in a recent SEC filing.

Chief People Officer Adam Y. Holton reports the acquisition of restricted stock units and an employee stock option in GE HealthCare Technologies Inc.

Chief Technology Officer Taha Kass-Hout reports acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.

Thomas J. Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted and performance stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., sold 2,000 shares of common stock at a price of $92.54 per share on February 18, 2025.

Peter Arduini, CEO of GE HealthCare Technologies Inc., reports the acquisition and disposal of common stock related to performance stock units (PSUs) that vested following the satisfaction of performance criteria.

James Saccaro, CFO of GE HealthCare Technologies Inc., disposed of shares to satisfy tax withholding obligations related to vesting restricted stock units.

CEO of Imaging at GE HealthCare Technologies, Roland Rott, disposed of 558 shares of common stock to cover tax obligations related to vesting restricted stock units.

Thomas J. Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 158 shares of common stock to cover tax obligations related to vesting restricted stock units.

Peter J. Arduini, a director and the President and CEO of GE HealthCare Technologies Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports the withholding of 444 common stock shares to cover tax obligations related to vesting restricted stock units on February 1, 2025.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.